Tumor-induced osteomalacia (TIO) is a rare acquired metabolic bone disorder occurring as a result of isolated renal phosphate wasting due to abnormal tumor production of fibroblast growth factor 23 (FGF23). Here, FGF23 is linked to neoplasm.